Key result
Low dialysate sodium reduces 48-hour aortic SBP by ~4 mmHg in intradialytic hypertension.
Why the study?
Intradialytic hypertension is associated with increased cardiovascular risk, and arterial stiffness may contribute to its development as affected patients exhibit higher ambulatory aortic BP and arterial stiffness.
Does low dialysate sodium concentration reduce ambulatory aortic blood pressure and arterial stiffness in patients with intradialytic hypertension?
RCT (n=29)
Single-blind
Block randomization
Yes
Does low dialysate sodium concentration reduce ambulatory aortic blood pressure and arterial stiffness in patients with intradialytic hypertension?
Low dialysate sodium concentration (137 mEq/L) significantly reduces 48-hour ambulatory aortic blood pressure and arterial stiffness in patients with intradialytic hypertension compared to standard concentration.
Supports low dialysate sodium for aortic BP control in intradialytic hypertension; provides first RCT data on 48-hour ambulatory measures.
INTRODUCTION: Intradialytic hypertension (IDH) is associated with increased cardiovascular risk. Arterial stiffness is a strong predictor of adverse outcomes in dialysis patients and may contribute to the development of the phenomenon, as patients with IDH exhibit higher ambulatory aortic blood pressure (BP) and arterial stiffness parameters than patients without IDH. Methods: This analysis examined the effect of low (137mEq/L) compared to standard (140mEq/L) dialysate sodium concentration on 48-hour aortic BP and arterial stiffness parameters in IDH patients. In this prespecified secondary analysis of a randomized, single-blind, crossover study, 29 IDH patients underwent four hemodialysis sessions with low followed by four sessions with standard dialysate sodium or vice-versa. Mean 48-hour, pre-/post-dialysis and intradialytic aortic systolic/diastolic BP (SBP/DBP), and arterial stiffness indices were assessed. RESULTS: Mean 48-hour aortic SBP/DBP were significantly lower with low versus standard dialysate sodium (124.1±16.4/83.0±14.1mmHg vs 128.5±12.9/85.8±14.1mmHg, p=0.013/p=0.006 respectively). Low dialysate sodium also significantly reduced pre-dialysis aortic SBP (126.4±17.4 vs 135.6±18.6mmHg, p=0.044) and post-dialysis aortic SBP (137.0±20.0 vs 147.9±18.1mmHg, p=0.01). All wave reflection indices were numerically lower with low dialysate sodium; among them, heart rate-adjusted augmentation index (AIx(75)) was significantly lower during the 48-hour (26.3±6.7 vs 27.7±5.8%, p=0.03), 44-hour, day-time and intradialytic periods. Low dialysate sodium resulted in decreased 48-hour pulse wave velocity (PWV) (9.9±2.5 vs 10.1±2.6m/s, p=0.008); similar differences for PWV were observed during all examined time intervals. CONCLUSIONS: In conclusion, ambulatory 48-hour aortic BP and arterial stiffness parameters were significantly lower using low compared to standard dialysate sodium in IDH patients. These findings further support the use of low dialysate sodium for BP management in this population.
No takes yet. Share an insight, caveat, or question.
Iatridi et al. (2025) conducted an RCT in Intradialytic hypertension in end-stage kidney disease (n=29). Low dialysate sodium concentration vs. Standard dialysate sodium concentration (140 mEq/L) was evaluated on Mean 48-hour aortic systolic blood pressure (mmHg) (Mean difference -4.4 mmHg, 95% CI -1.00 to -7.8, p=0.013). Low dialysate sodium (137 mEq/L) significantly reduced mean 48-hour aortic systolic blood pressure by 4.4 mmHg compared to standard dialysate sodium in patients with intradialytic hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: